vs
Side-by-side financial comparison of BJs RESTAURANTS INC (BJRI) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
BJs RESTAURANTS INC is the larger business by last-quarter revenue ($355.4M vs $37.2M, roughly 9.5× Organogenesis Holdings Inc.). On growth, BJs RESTAURANTS INC posted the faster year-over-year revenue change (3.2% vs -57.1%). Over the past eight quarters, BJs RESTAURANTS INC's revenue compounded faster (2.6% CAGR vs -46.5%).
BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
BJRI vs ORGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $355.4M | $37.2M |
| Net Profit | $12.6M | — |
| Gross Margin | 74.5% | 30.8% |
| Operating Margin | 3.1% | -185.1% |
| Net Margin | 3.6% | — |
| Revenue YoY | 3.2% | -57.1% |
| Net Profit YoY | -24.2% | — |
| EPS (diluted) | $0.58 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $37.2M | ||
| Q4 25 | $355.4M | $225.6M | ||
| Q3 25 | $365.6M | $150.9M | ||
| Q2 25 | $348.0M | $101.0M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | $325.7M | $126.7M | ||
| Q3 24 | $349.9M | $115.2M | ||
| Q2 24 | $337.3M | $130.2M |
| Q1 26 | — | — | ||
| Q4 25 | $12.6M | $43.7M | ||
| Q3 25 | $22.2M | $21.6M | ||
| Q2 25 | $13.5M | $-9.4M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | $-2.9M | $7.7M | ||
| Q3 24 | $17.2M | $12.3M | ||
| Q2 24 | $7.7M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | 74.5% | — | ||
| Q3 25 | 75.2% | — | ||
| Q2 25 | 75.0% | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | 73.4% | 75.5% | ||
| Q3 24 | 74.3% | 76.7% | ||
| Q2 24 | 74.8% | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | 3.1% | 28.1% | ||
| Q3 25 | 5.8% | 13.7% | ||
| Q2 25 | 4.3% | -12.5% | ||
| Q1 25 | — | -30.9% | ||
| Q4 24 | -0.8% | 8.1% | ||
| Q3 24 | 3.8% | 5.4% | ||
| Q2 24 | 2.4% | -10.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 19.4% | ||
| Q3 25 | 6.1% | 14.3% | ||
| Q2 25 | 3.9% | -9.3% | ||
| Q1 25 | — | -21.7% | ||
| Q4 24 | -0.9% | 6.1% | ||
| Q3 24 | 4.9% | 10.7% | ||
| Q2 24 | 2.3% | -13.1% |
| Q1 26 | — | — | ||
| Q4 25 | $0.58 | $0.31 | ||
| Q3 25 | $0.97 | $0.11 | ||
| Q2 25 | $0.58 | $-0.10 | ||
| Q1 25 | — | $-0.17 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | $0.72 | $0.09 | ||
| Q2 24 | $0.32 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.8M | $91.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $366.2M | — |
| Total Assets | $1.0B | $520.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | $23.8M | $93.7M | ||
| Q3 25 | $26.0M | $63.7M | ||
| Q2 25 | $19.0M | $73.1M | ||
| Q1 25 | — | $110.0M | ||
| Q4 24 | $18.4M | $135.6M | ||
| Q3 24 | $16.2M | $94.3M | ||
| Q2 24 | $18.8M | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $60.5M | — | ||
| Q2 25 | $85.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $66.5M | — | ||
| Q3 24 | $63.5M | $62.3M | ||
| Q2 24 | $58.0M | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | $366.2M | $300.1M | ||
| Q3 25 | $386.6M | $255.1M | ||
| Q2 25 | $371.5M | $233.2M | ||
| Q1 25 | — | $242.9M | ||
| Q4 24 | $376.2M | $262.9M | ||
| Q3 24 | $386.5M | $278.5M | ||
| Q2 24 | $375.4M | $263.5M |
| Q1 26 | — | $520.0M | ||
| Q4 25 | $1.0B | $598.7M | ||
| Q3 25 | $1.0B | $509.8M | ||
| Q2 25 | $1.0B | $461.1M | ||
| Q1 25 | — | $467.4M | ||
| Q4 24 | $1.0B | $497.9M | ||
| Q3 24 | $1.0B | $446.3M | ||
| Q2 24 | $1.0B | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.16× | 0.22× | ||
| Q2 24 | 0.15× | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
